Alberto Tolcachier

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 311 citations

Pharmacy, Pharmacology, Pharmacotherapy +6

Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study

Wytske J. Fokkens, Andrew Trigg, Stella E. Lee et al. · Journal of Patient-Reported Outcomes · 2023 · 16 citations · Full text

Medicine, Otolaryngology, Pharmacotherapy +14

Dupilumab efficacy and safety in Latin American patients with uncontrolled, moderate-to-severe asthma: phase 3 LIBERTY ASTHMA QUEST study

Jorge Máspero, Guido Cardona, Patricia Schonffeldt et al. · Journal of Asthma · 2022 · 11 citations · Full text

Medicine, Internal Medicine, Pharmacology +14